Indeed, further analyses have revealed that GLS2 silencing substantially reduced proliferation and clonogenic potential in two MYCN-amplified neuroblastoma cell lines, Kelly and BE-2C, and attenuated their ability to form tumors in vivo. This evidence concerns the gene GLS2 and neuroblastoma.